Dr. Abud Bakri

That is also true.

It could go both ways.

But they were more interested in performance.

They wanted better astronauts, better Olympians, better soldiers.

We care more about, you know, a profit drug model that gets people on a subscription with a monthly drug, unfortunately.

Okay.

And it depends on medical boards.

To break it down, BPC-157 never got FDA approved, right?

So it gets into these compounding pharmacy lists.

There's a category one, two, and three.

Category one means the FDA thinks like, hey, this is not an approved drug, but we're okay with you compounding this and you're okay to push that forward.

Category two, it's like, do not compound.

In late 2024, BPC-157 and 20 other peptides got moved to this category two list.

Since about 2017 to 2024-

People have been prescribing BPC in these alternative medicine anti-aging practices.

It gets removed from that list.

Of course, you know, compounded pharmacies re-label it as PDA, pedodecapeptide arginate.

But it's the same thing.

It's the same, exactly.

Really?